Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) shares rose 11.3% during trading on Monday . The stock traded as high as $1.15 and last traded at $1.11. Approximately 237,045 shares were traded during mid-day trading, a decline of 62% from the average daily volume of 617,436 shares. The stock had previously closed at $1.00.
Curaleaf Stock Performance
The firm has a 50 day moving average price of $0.88 and a 200-day moving average price of $1.05. The company has a debt-to-equity ratio of 1.08, a quick ratio of 0.70 and a current ratio of 1.41. The company has a market cap of $831.04 million, a P/E ratio of -4.00 and a beta of 0.62.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.07) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.07). Curaleaf had a negative return on equity of 14.12% and a negative net margin of 17.37%. On average, research analysts predict that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.
About Curaleaf
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
